Clinical Trial Update: Impact of XDEMVY® on Demodex Blepharitis in Soft Contact Lens Wearers [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating XDEMVY for Demodex blepharitis in soft contact lens wearers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Demodex Blepharitis

Drugs mentioned

• XDEMVY (lotilaner)

Snippet

Sponsor: Tarsus Pharmaceuticals, Inc. | Conditions: Demodex Blepharitis | Phase 4 | Status: COMPLETED